4893 items matching your search terms.

Development and validation of a nomogram to predict survival in CALYPSO and AGO-2.5 patients with platinum sensitive recurrent ovarian cancer

Lee, C Simes, J Gebski, V Wollschlaeger, K Plante, M Vergote, I Mäenpää, J Ferrero, A Pisano, C Parma, G Berton-Rigaud, D Schröder, W Bentley, J Reinthaller, A Schmalfeldt, B Hirte, H Pfisterer, J Pujade-Lauraine, E Friedlander, M

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Lee, CK; Gurney, H; Brown, C; Sorio, R; Donadello, N; Tulunay, G; Meier, W; Bacon, M; Maenpaa, J; Petru, E; Reed, N; Gebski, V; Pujade-Lauraine, E; Lord, S; Simes, RJ; Friedlander, M
BRITISH JOURNAL OF CANCER, 2011     DOI:10.1038/bjc.2011.256

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

Lee, CK; Simes, RJ; Brown, C; Lord, S; Wagner, U; Plante, M; Vergote, I; Pisano, C; Parma, G; Burges, A.; Bourgeois, H; Hogberg, T; Bentley, J; Angleitner-Boubenizek, L; Ferrero, A; Richter, B; Hirte, H; Gebski, V; Pfisterer, J; Pujade-Lauraine, E; Friedlander, M
BRITISH JOURNAL OF CANCER, 2011     DOI:10.1038/bjc.2011.364

Review of compliance with WHO breastfeeding guidelines

Lewis, S Wortley, S Ko, H Willson, M Schofield, D

Morphologic and immunohistochemical changes in metastatic melanoma tissue and associations with clinical outcome in patients on BRAF inhibitors

Long, GV Wilmott, JS Howle, JR Chatfield, MD Tembe, V Thompson, JF Hersey, P Mann, GJ McArthur, GA Rizos, H Young, RJ Scurr, LL Sharma, RN Kefford, RF Scolyer, RA

Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice

Lord, SJ Staub, LP Bossuyt, PM Irwig, LM
BMJ (CLINICAL RESEARCH ED.), 2011     DOI:10.1136/bmj.d4684

Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis

Luckett, T Goldstein, D Butow, PN Gebski, V Aldridge, LJ McGrane, J Ng, W King, MT

Need for global partnership in cancer care: perceptions of cancer care researchers attending the 2010 Australia and Asia Pacific Clinical Oncology Research Development Workshop

Lyerly, HK Abernethy, AP Stockler, MR Koczwara, B Aziz, Z Nair, R Seymour, L

Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial

Mahner, S Meier, W du Bois, A Brown, C Lorusso, D Ferrero, AM Cretin J, Havsteen, H Bessette, P Angleitner-Boubenizek, L Vergote, I Vasey, P Gebski, V Slama, B Herrstedt, J Kaizer, L Georgoulopoulos, A Reed, N Wagner, U

Cytokines' profiles to predict chemotherapy outcome in castration-resistant prostate cancer

Mahon, KL Chatfield, MD Lee-Ng, M Breit, SN Brown, DA Molloy, MP Marx, GM Pavlakis, N Boyer, MJ Stockler, MR Wykes, R Henshall, SM Sutherland, RL Horvath, L

Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: a FIELD substudy

Maranghi, M Hiukka, A Badeau, R Sundvall, J Jauhiainen, M Taskinen, M-R
ATHEROSCLEROSIS, 2011     DOI:10.1016/j.atherosclerosis.2011.05.018

Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients: treatment at recurrence and overall survival final analysis from CALYPSO phase III GCIG trial

Marth, C Alexandre, J Hanker, L Brown, C Kaem, J Heywood, M Bonaventura, A Vergote, I Pignata, S Ferrero, AM Gebski, V Gropp, M Skeie-Jensen, T Giede, C Vasey, P Schauer, C Reed, N Ferrandina, G Fossati, R Pujade-Lauraine, E

Identification of infants with major cognitive delay using parental report

Martin, AJ Darlow, BA Salt, A Hague, W Sebastian, L Mann, K Tarnow-Mordi, W on behalf of the INIS Trial Collaborative Group,

Estimating survival after adjuvant chemotherapy for resected NSCLC

McCaughan, G Blinman, P Boyer, M Stockler, M

Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer

McCaughan, GJ Boyer, M Stockler, M Blinman, PL